Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.
Open Access
- 1 June 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 77 (12) , 2138-2147
- https://doi.org/10.1038/bjc.1998.358
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- 4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid ReceptorsJournal of Biological Chemistry, 1996
- Insulin-like Growth Factors in Health and DiseaseAnnals of Internal Medicine, 1992
- Expression and regulation of retinoic acid receptors in human breast cancer cells.1992
- 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PONucleic Acids Research, 1991
- Retinoic acid is a negative regulator of AP-1-responsive genes.Proceedings of the National Academy of Sciences, 1991
- Identification of insulin-like growth factor binding proteins in breast cancer cellsBreast Cancer Research and Treatment, 1991
- Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells.1990
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- N-(4-HYDROXYPHENYL)RETINAMIDE - NEW RETINOID FOR PREVENTION OF BREAST-CANCER IN THE RAT1979
- DIFFERENT SUSCEPTIBILITIES OF HUMAN MELANOMA AND BREAST-CARCINOMA CELL-LINES TO RETINOIC ACID-INDUCED GROWTH-INHIBITION1979